Literature DB >> 22906773

[How to treat systemic necrotizing vasculitides?].

Loïc Guillevin1.   

Abstract

Corticosteroids and, according to severity or vasculitis type, cytotoxic agents are prescribed to treat systemic necrotizing vasculitides. Usually, in most vasculitides, treatment is prescribed for at least 18 months. Treatment is able to obtain a remission in approximatively 90% of patients. Relapse rate is high. Cyclophosphamide is usually prescribed for a few months, and administered by pulses. A maintenance treatment is compulsory and comprises usually azathioprine and methotrexate. Biologics can be proposed as ad on therapy like intravenous immunoglobulins and anti-TNF. Rituximab, an anti-CD20 drug is as effective as cyclophosphamide. It can be also prescribed to maintain remission.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906773     DOI: 10.1016/j.lpm.2012.06.008

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

Review 1.  Treatment of primary systemic necrotizing vasculitides: the role of biotherapies.

Authors:  Loïc Guillevin
Journal:  Clin Exp Nephrol       Date:  2013-09-10       Impact factor: 2.801

Review 2.  Anti-TNF-alpha therapy and systemic vasculitis.

Authors:  Pierre-André Jarrot; Gilles Kaplanski
Journal:  Mediators Inflamm       Date:  2014-02-27       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.